£56.94

Morgan & Claypool Molecular Pathology of Alzheimer's Disease (Colloquium Series on Neurobiology of Alzheimer's Disease)

Price data last checked 44 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£57 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 47 days · 47 data points (no recent data)

Historical
Generating forecast…
£56.95 £56.94 £56.94 £56.94 £56.95 £56.95 £56.95 10 June 2026 21 June 2026 03 July 2026 14 July 2026 26 July 2026

Price Distribution

Price distribution over 47 days • 1 price levels

Days at Price
47 days 0 12 24 35 47 £57 Days at Price

Price Analysis

Most common price: £57 (47 days, 100.0%)

Price range: £57 - £57

Price levels: 1 different prices over 47 days

Description

Alzheimer's Disease is characterized pathologically by two principal hallmark lesions: the senile plaque and the neurofibrillary tangle. Since the identification of each over 100 years ago, the major protein components have been elucidated. This has led in turn to the elaboration of metabolic cascades involving amyloid-β production in the case of the senile plaque, and phosphorylated-tau protein in the case of the neurofibrillary tangle. The pathogenesis and histogenesis of each have been the source of extensive investigation and some controversy in recent years, as both cascades have been implicated in the pathogenesis of Alzheimer's Disease, relied upon in the diagnostic criteria for Alzheimer's Disease at autopsy, and targeted for therapeutic intervention. With the accumulation of data and expansion of knowledge of the molecular biology of Alzheimer's Disease, it appears that the enthusiasm for successful intervention has been premature. In this book, we detail the discovery and characterization of the major pathological lesions, their associated molecular biology, their relationship to clinical disease, and potential fundamental errors in understanding that may be leading scientific investigators in unintended directions. Table of Contents: Introduction / Plaques / Neurofibrillary Degeneration / Complexities / Synopsis and Conclusion / References / Author Biographies

Key Features

Pages Count - 92. Binding type - Perfect.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 October 2013
Listed Since
06 November 2013

Barcode

No barcode data available

Similar Products You Might Like

Alzheimer’s Disease: Lessons from Cell Biology (Research and Perspectives in Alzheimer's Disease)
97% match

Alzheimer’s Disease: Lessons from Cell Biology (Research and Perspectives in Alzheimer's Disease)

Springer

£76.63 30 Jun 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Jul 2026
The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)
96% match

The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)

Cold Spring Harbor Laboratory Press

£85.00 19 Aug 2026
ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)
96% match

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (Molecular Medicine And Medicinal Chemistry)

Imperial College Press

£80.01 30 Jun 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.81 09 Jul 2026
Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)
96% match

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)

Springer

£161.77 18 Jul 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
96% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£66.04 10 Jul 2026
Memory Loss, Alzheimer's Disease and Dementia: A Practical Guide for Clinicians
96% match

Memory Loss, Alzheimer's Disease and Dementia: A Practical Guide for Clinicians

Elsevier

£62.39 21 Aug 2026
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)
96% match

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)

Wiley

£181.99 18 Aug 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
96% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£136.75 21 Aug 2026
Neuroprotection in Alzheimer's Disease
96% match

Neuroprotection in Alzheimer's Disease

Academic Press

£88.59 10 Jul 2026
Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation
96% match

Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation

CRC Press

£170.00 20 Aug 2026
Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)
96% match

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Springer

£129.99 17 Jul 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)
96% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

CRC Press

£225.26 18 Aug 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 03 Jul 2026
Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics
96% match

Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics

Wiley

£49.34 11 Aug 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
96% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Academic Press

£113.59 10 Jul 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
96% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£11.43 04 Jul 2026
Springer - Genotype-Proteotype-Phenotype Neurodegeneration Book
96% match

Springer - Genotype-Proteotype-Phenotype Neurodegeneration Book

Springer

£113.93 17 Jul 2026
Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry, 38)
96% match

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry, 38)

Springer

£127.32 23 Jul 2026
Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)
96% match

Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)

Humana

£140.56 21 Aug 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)
96% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)

CRC Press

£62.99 03 Jul 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
96% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£69.91 03 Jul 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
96% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£105.49 09 Jul 2026